Abstract

Infliximab 1% Ophthalmic Solution

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2017 - Volume 21, Number 1

Page(s): 62

Download in electronic PDF format for $75

Abstract

A formulation for preparing Infliximab 1% Ophthalmic Solution. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2017 Pg. 62	Infliximab 1% Ophthalmic Solution Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 418-426	Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation Author(s): Robert Marie-Claude, Spurr-Michaud Sandra, Frenette Mathieu, Young David, Gipson Ilene K, Dohlman Claes H
Nov/Dec 2022 Pg. 446-466	Compounding with Biotechnology Products, Part 2: Product-specific Considerations Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 399-404	Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 495-500	Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments Author(s): Allen Loyd V Jr
Jan/Feb 2004 Pg. 46-48	Basics of Compounding for Disorders of the External Ear Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 481-486	Basics of Compounding: Compounding Irrigation Solutions for Sterile and Nonsterile Preparations Author(s): Allen Loyd V Jr
Nov/Dec 2009 Pg. 506-515	Autologous Eye Drops for the Treatment of Dry Eye and Neurotrophic Keratitis Author(s): Mixon William, Angelle Patricea (Patsy), Chang Richard I
Jan/Feb 2015 Pg. 70-72	Stability Assessment of Repackaged Bevacizumab for Intravitreal Administration Author(s): Pereboom Marieke, Becker Matthijs L, Amenchar Mostapha, Verweij Sjoerd L, van der Hoeven Ruud TM, Mulder Inge J
Jan/Feb 2008 Pg. 8-14	Intravitreal Bevacizumab for Choroidal Neovascularization in Age-Related Macular Degeneration Author(s): Dib Jean G, Abdulmohsin Saud
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
May/Jun 2015 Pg. 242	Atropine Sulfate 1% Ophthalmic Solution Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 190-195	I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease Author(s): McElhiney Linda F
May/Jun 2017 Pg. 223-228	Basics of Sterile Compounding: Manipulating Peptides and Proteins Author(s): Akers Michael J
Nov/Dec 2015 Pg. 508	Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 64	Tetracaine Hydrochloride 0.5% Ophthalmic Solution Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 500	Cefepime 1% Ophthalmic Solution Author(s): Allen Loyd V Jr
Nov/Dec 2009 Pg. 540-543	Quality-Control Analytical Methods: Applications and Sterility of Autologous Eye Drops Author(s): Reed-Kane Dana, Carlson Rachel A, Kupiec Thomas C, Vu Nicole
Sep/Oct 2010 Pg. 421	Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 319	Gatifloxacin 0.5% Ophthalmic Solution Author(s): Allen Loyd V Jr